Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer’s, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors, showcasing the potential of multiomic approaches in personalized medicine.
Dr. Reddy’s, Torrent Pharma and Laurus Synthesis all land Form 483 letters following FDA inspections
In December the FDA hit India-based Torrent Pharmaceuticals, Laurus Synthesis and Dr. Reddy’s Laboratories each with Form 483 letters published on Dec. 28. This was
January 4, 2024